Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.2366
+0.0076 (3.32%)
At close: Feb 23, 2026, 4:00 PM EST
0.2350
-0.0016 (-0.68%)
After-hours: Feb 23, 2026, 7:59 PM EST
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $8.36 million as of February 23, 2026. Its market cap has decreased by -90.31% in one year.
Market Cap
8.36M
Enterprise Value
9.08M
1-Year Change
-90.31%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $8.36M, a decrease of -97.58%. That is a compound annual growth rate of -54.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 8.36M | -49.36% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 8.80M |
| NuCana | 8.74M |
| GridAI Technologies | 8.67M |
| Quince Therapeutics | 8.36M |
| Ernexa Therapeutics | 8.26M |
| XTL Biopharmaceuticals | 8.19M |
| BiomX | 8.14M |
| CalciMedica | 7.80M |